<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39368662</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7492</ISSN><JournalIssue CitedMedium="Internet"><Volume>350</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>05</Day></PubDate></JournalIssue><Title>Virus research</Title><ISOAbbreviation>Virus Res</ISOAbbreviation></Journal><ArticleTitle>Viral coexistence and insertional mutations in the ORF8 region of SARS-CoV-2: A possible mechanism of nucleotide insertion.</ArticleTitle><Pagination><StartPage>199478</StartPage><MedlinePgn>199478</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">199478</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virusres.2024.199478</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0168-1702(24)00171-0</ELocationID><Abstract><AbstractText>The virus obtained from a swab sample ID: S66 in Hiroshima was reported to have a single T-base insertion in the ORF8 coding region. However, no T insertion was observed when we determined the genomic sequence using another method. We then extracted RNA from the S66 swab sample and sequenced the insertion site using the Sanger method. The resulting waveform was disrupted beyond the insertion site, suggesting the presence of a mixed population of viruses with different sequences. Through plasmid cloning of RT-PCR amplification fragments and virus cloning by limiting dilution, along with TIDE analysis to determine the ratio of components from the Sanger sequencing waveform, it was confirmed that the sample contained a mixture of viruses with varying numbers of T-base insertions. The virus with one T insertion (T1+) was predominant in 70-75 % of the genomes, and genomes with T0, T2+, T3+, T4+, and T5+ were also detected. No T-base insertion mutations were observed in the ORF8 region in three other SARS-CoV-2 samples. In the S66 sample, a C27911T point mutation near the insertion site in the ORF8 region resulted in a sequence of seven or more consecutive T bases, which was the cause of the T-base insertion. When the cloned S66 virus (T1+) was passaged in cultured cells, there was a tendency for viruses with more insertion bases to become dominant with successive generations, suggesting that the T-base insertion was due to polymerase stuttering. The insertion of T bases resulted in synthesis of deletion mutants of the ORF8 protein, but no significant change was observed in the proliferation of the viruses in cultured cells. A search of the GenBank database using NCBI BLAST for viruses similar to S66 with T-base insertion mutations revealed hundreds of viruses widely distributed on the molecular phylogenetic tree. These base insertion viruses were thought to have occasionally arisen during the virus infection process. This study suggests one mechanism of insertion mutations in SARS-CoV-2, and it is important to consider the emergence of future mutant strains.</AbstractText><CopyrightInformation>Copyright © 2024. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kurose</LastName><ForeName>Miuko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Akima</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elsayed</LastName><ForeName>Abeer Mohamed Abdelfattah</ForeName><Initials>AMA</Initials><AffiliationInfo><Affiliation>Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawal-Ayinde</LastName><ForeName>Basirat Mojisola</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nomura</LastName><ForeName>Toshihito</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan; Department of Infectious Diseases, Hiroshima University Hospital, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higashiura</LastName><ForeName>Akifumi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irie</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukushi</LastName><ForeName>Masaya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanda</LastName><ForeName>Miyuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Collaborative Laboratory of Liquid Biopsy, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tahara</LastName><ForeName>Hidetoshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cellular and Molecular Biology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morita</LastName><ForeName>Daichi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuroda</LastName><ForeName>Teruo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Ko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Infectious Disease Control, and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Kazuaki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Infectious Disease Control, and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Junko</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Infectious Disease Control, and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakaguchi</LastName><ForeName>Takemasa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. Electronic address: tsaka@hiroshima-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virus Res</MedlineTA><NlmUniqueID>8410979</NlmUniqueID><ISSNLinking>0168-1702</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Covid-19</Keyword><Keyword MajorTopicYN="N">NGS analysis</Keyword><Keyword MajorTopicYN="N">Polymerase stuttering</Keyword><Keyword MajorTopicYN="N">T-base insertions</Keyword><Keyword MajorTopicYN="N">TIDE analysis</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>5</Day><Hour>19</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39368662</ArticleId><ArticleId IdType="pmc">PMC11491963</ArticleId><ArticleId IdType="doi">10.1016/j.virusres.2024.199478</ArticleId><ArticleId IdType="pii">S0168-1702(24)00171-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aksamentov I., Roemer C., Hodcroft E., Neher R. Nextclade: clade assignment, mutation calling and quality control for viral genomes. J. Open Source Softw. 2021;6(67):3773. doi: 10.21105/joss.03773.</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.03773</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Perez M., Hurtado-Tamayo J., Mykytyn A.Z., Lamers M.M., Requena-Platek R., Schipper D., Munoz-Santos D., Ripoll-Gomez J., Esteban A., Sanchez-Cordon P.J., Enjuanes L., Haagmans B.L., Sola I. SARS-CoV-2 ORF8 accessory protein is a virulence factor. MBio. 2023;14(5) doi: 10.1128/mbio.00451-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00451-23</ArticleId><ArticleId IdType="pmc">PMC10653805</ArticleId><ArticleId IdType="pubmed">37623322</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkman E.K., Chen T., Amendola M., van Steensel B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 2014;42(22):e168. doi: 10.1093/nar/gku936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku936</ArticleId><ArticleId IdType="pmc">PMC4267669</ArticleId><ArticleId IdType="pubmed">25300484</ArticleId></ArticleIdList></Reference><Reference><Citation>Carabelli A.M., Peacock T.P., Thorne L.G., Harvey W.T., Hughes J., Consortium C.-G.U., Peacock S.J., Barclay W.S., de Silva T.I., Towers G.J., Robertson D.L. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat. Rev. Microbiol. 2023;21(3):162–177. doi: 10.1038/s41579-022-00841-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00841-7</ArticleId><ArticleId IdType="pmc">PMC9847462</ArticleId><ArticleId IdType="pubmed">36653446</ArticleId></ArticleIdList></Reference><Reference><Citation>Danecek P., Bonfield J.K., Liddle J., Marshall J., Ohan V., Pollard M.O., Whitwham A., Keane T., McCarthy S.A., Davies R.M., Li H. Twelve years of SAMtools and BCFtools. Gigascience. 2021;10(2) doi: 10.1093/gigascience/giab008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gigascience/giab008</ArticleId><ArticleId IdType="pmc">PMC7931819</ArticleId><ArticleId IdType="pubmed">33590861</ArticleId></ArticleIdList></Reference><Reference><Citation>Deatherage D.E., Barrick J.E. Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. Methods Mol. Biol. 2014;1151:165–188. doi: 10.1007/978-1-4939-0554-6_12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-0554-6_12</ArticleId><ArticleId IdType="pmc">PMC4239701</ArticleId><ArticleId IdType="pubmed">24838886</ArticleId></ArticleIdList></Reference><Reference><Citation>Dettwiler I., Troell K., Robinson G., Chalmers R.M., Basso W., Renteria-Solis Z.M., Daugschies A., Muhlethaler K., Dale M.I., Basapathi Raghavendra J., Ruf M.T., Poppert S., Meylan M., Olias P. TIDE analysis of cryptosporidium infections by gp60 typing reveals obscured mixed infections. J. Infect. Dis. 2022;225(4):686–695. doi: 10.1093/infdis/jiab417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab417</ArticleId><ArticleId IdType="pubmed">34417806</ArticleId></ArticleIdList></Reference><Reference><Citation>Duchene S., Featherstone L., Haritopoulou-Sinanidou M., Rambaut A., Lemey P., Baele G. Temporal signal and the phylodynamic threshold of SARS-CoV-2. Virus Evol. 2020;6(2):veaa061. doi: 10.1093/ve/veaa061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veaa061</ArticleId><ArticleId IdType="pmc">PMC7454936</ArticleId><ArticleId IdType="pubmed">33235813</ArticleId></ArticleIdList></Reference><Reference><Citation>Garushyants S.K., Rogozin I.B., Koonin E.V. Template switching and duplications in SARS-CoV-2 genomes give rise to insertion variants that merit monitoring. Commun. Biol. 2021;4(1):1343. doi: 10.1038/s42003-021-02858-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02858-9</ArticleId><ArticleId IdType="pmc">PMC8632935</ArticleId><ArticleId IdType="pubmed">34848826</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein S.A., Hogue B.G., Leibowitz J.L., Weiss S.R., 2023. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In: Howley P.M., Knipe D.M. (Eds.), Fields Virology. Vol. 7th ed. 4 vols. WOLTERS KLUWER, Philadelphia, PA, USA, pp. 706–740. ISBN:978-1-9751-1260-8.</Citation></Reference><Reference><Citation>Hausmann S., Garcin D., Delenda C., Kolakofsky D. The versatility of paramyxovirus RNA polymerase stuttering. J. Virol. 1999;73(7):5568–5576. doi: 10.1128/JVI.73.7.5568-5576.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.7.5568-5576.1999</ArticleId><ArticleId IdType="pmc">PMC112614</ArticleId><ArticleId IdType="pubmed">10364305</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiroshima Prefecture, 2023. Hiroshima prefecture's policy for prevention of the spread of the novel coronavirus. https://www.pref.hiroshima.lg.jp/site/2019-ncov/covid19-level-change.html.</Citation></Reference><Reference><Citation>Kee J., Thudium S., Renner D.M., Glastad K., Palozola K., Zhang Z., Li Y., Lan Y., Cesare J., Poleshko A., Kiseleva A.A., Truitt R., Cardenas-Diaz F.L., Zhang X., Xie X., Kotton D.N., Alysandratos K.D., Epstein J.A., Shi P.Y., Yang W., Morrisey E., Garcia B.A., Berger S.L., Weiss S.R., Korb E. SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry. Nature. 2022;610(7931):381–388. doi: 10.1038/s41586-022-05282-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05282-z</ArticleId><ArticleId IdType="pmc">PMC9533993</ArticleId><ArticleId IdType="pubmed">36198800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko K., Nagashima S., E B., Ouoba S., Akita T., Sugiyama A., Ohisa M., Sakaguchi T., Tahara H., Ohge H., Ohdan H., Kubo T., Kishita E., Kuwabara M., Takahashi K., Tanaka J. Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan. PLoS One. 2021;16(2) doi: 10.1371/journal.pone.0246383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246383</ArticleId><ArticleId IdType="pmc">PMC7864667</ArticleId><ArticleId IdType="pubmed">33544733</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X., Fu B., Yin S., Li Z., Liu H., Zhang H., Xing N., Wang Y., Xue W., Xiong Y., Zhang S., Zhao Q., Xu S., Zhang J., Wang P., Nian W., Wang X., Wu H. ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway. iScience. 2021;24(4) doi: 10.1016/j.isci.2021.102293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102293</ArticleId><ArticleId IdType="pmc">PMC7942160</ArticleId><ArticleId IdType="pubmed">33723527</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama S., Nao N., Shirato K., Kawase M., Saito S., Takayama I., Nagata N., Sekizuka T., Katoh H., Kato F., Sakata M., Tahara M., Kutsuna S., Ohmagari N., Kuroda M., Suzuki T., Kageyama T., Takeda M. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc. Natl. Acad. Sci. U. S. A. 2020;117(13):7001–7003. doi: 10.1073/pnas.2002589117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2002589117</ArticleId><ArticleId IdType="pmc">PMC7132130</ArticleId><ArticleId IdType="pubmed">32165541</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazmul T., Lawal-Ayinde B.M., Morita T., Yoshimoto R., Higashiura A., Yamamoto A., Nomura T., Nakano Y., Hirayama M., Kurokawa H., Kitamura Y., Hori K., Sakaguchi T. Capture and neutralization of SARS-CoV-2 and influenza virus by algae-derived lectins with high-mannose and core fucose specificities. Microbiol. Immunol. 2023;67(7):334–344. doi: 10.1111/1348-0421.13082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1348-0421.13082</ArticleId><ArticleId IdType="pubmed">37248051</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashid F., Dzakah E.E., Wang H., Tang S. The ORF8 protein of SARS-CoV-2 induced endoplasmic reticulum stress and mediated immune evasion by antagonizing production of interferon beta. Virus Res. 2021;296 doi: 10.1016/j.virusres.2021.198350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2021.198350</ArticleId><ArticleId IdType="pmc">PMC7897408</ArticleId><ArticleId IdType="pubmed">33626380</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization - WHO, 2023. Weekly epidemiological update on COVID-19 - 27 July 2023. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19—27-july-2023.</Citation></Reference><Reference><Citation>Wu X., Xia T., Shin W.J., Yu K.M., Jung W., Herrmann A., Foo S.S., Chen W., Zhang P., Lee J.S., Poo H., Comhair S.A.A., Jehi L., Choi Y.K., Ensser A., Jung J.U. Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8. MBio. 2022;13(2) doi: 10.1128/mbio.00402-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00402-22</ArticleId><ArticleId IdType="pmc">PMC9040823</ArticleId><ArticleId IdType="pubmed">35343786</ArticleId></ArticleIdList></Reference><Reference><Citation>Young B.E., Fong S.W., Chan Y.H., Mak T.M., Ang L.W., Anderson D.E., Lee C.Y., Amrun S.N., Lee B., Goh Y.S., Su Y.C.F., Wei W.E., Kalimuddin S., Chai L.Y.A., Pada S., Tan S.Y., Sun L., Parthasarathy P., Chen Y.Y.C., Barkham T., Lin R.T.P., Maurer-Stroh S., Leo Y.S., Wang L.F., Renia L., Lee V.J., Smith G.J.D., Lye D.C., Ng L.F.P. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet. 2020;396(10251):603–611. doi: 10.1016/S0140-6736(20)31757-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31757-8</ArticleId><ArticleId IdType="pmc">PMC7434477</ArticleId><ArticleId IdType="pubmed">32822564</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen Y., Li Y., Huang F., Luo B., Yuan Y., Xia B., Ma X., Yang T., Yu F., Liu J., Liu B., Song Z., Chen J., Yan S., Wu L., Pan T., Zhang X., Li R., Huang W., He X., Xiao F., Zhang J., Zhang H. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Iota. Proc. Natl. Acad. Sci. U. S. A. 2021;118(23) doi: 10.1073/pnas.2024202118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024202118</ArticleId><ArticleId IdType="pmc">PMC8201919</ArticleId><ArticleId IdType="pubmed">34021074</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H., Lee H.A., Palese P., Garcia-Sastre A. Influenza A virus RNA polymerase has the ability to stutter at the polyadenylation site of a viral RNA template during RNA replication. J. Virol. 1999;73(6):5240–5243. doi: 10.1128/JVI.73.6.5240-5243.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.6.5240-5243.1999</ArticleId><ArticleId IdType="pmc">PMC112577</ArticleId><ArticleId IdType="pubmed">10233995</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>